… It stimulates the blood cells to attack any form of tumor or entity that it's been exposed to through the vaccine. We're able to use it in the cancer cell to detect it. "By identifying that, we're able to use that against the tumor to test it in the blood stream and detect it early. "We've isolated the proteins that come off of these tumor cells," he said.
KEYMO ALTERNATIVE SERIES
It will be administered through a series of shots.
It works by using proteins from tumor cells to fight back against cancerous cells, he said. The vaccination has shown positive testing results so far, Dahlbeck said. Jennifer Rodriguez, press officer in the office of media affairs for the FDA, said in an emailed statement following an inquiry about the drug, "Federal law prohibits the FDA from confirming the existence of, or releasing information about, an Investigational New Drug application." The company received the FDA approval notice by email on Feb. … You can't even study it in humans without all that." "The FDA gives approval called an IND (Investigational New Drug). "We've done all the preclinical work to present it to the FDA," Dahlbeck said. Scott Dahlbeck, chief executive officer of Kiromic LLC, the company that developed the vaccine. The vaccine, identified as the Kiro VAX series, will be available in clinical trials in Lubbock in May, said Dr. The Food and Drug Administration has approved a cancer vaccine developed by local doctors to go to clinical trials.
Local cancer patients could have the option to try a "natural" alternative to chemotherapy and other drugs for cancer treatment.
0 kommentar(er)
